Skip to search.
 FTSE 100 Up 0.08%

BIND Therapeutics, Inc. (BIND)

-NasdaqGS
0.42 Down 0.01(2.33%) 27 May 20:58
Prev Close:0.43
Open:0.44
Bid:0.27 x 1000
Ask:0.47 x 2000
1y Target Est:6.58
Beta:N/A
Earnings Date:4 Aug - 8 Aug (Est.)
Day's Range:0.40 - 0.45
52wk Range:0.35 - 6.22
Volume:227,186
Avg Vol (3m):490,050
Market Cap:8.77m
P/E (ttm):N/A
EPS (ttm):-1.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BIND at this time.

Comparison

Symbol% ChgMkt Cap
BINDDown 2.33%8.77m
PGNXUp 2.52%342.04m
BMYUp 0.82%119.04b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.47
Quarterly EPS Est (Jun-16) :-0.45
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BIND Therapeutics, Inc., a biotechnology company, develops novel targeted therapeutics primarily for the treatment of cancer in the United States and Russia. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback